Stock 000999 CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Equities

000999

CNE0000011K8

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
64.65 CNY +0.02% Intraday chart for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. +4.56% +30.00%
Jun. 10 CR Sanjiu Medical and Pharmaceutical to Sell 51% of China Resources Shenghuo for 1.79 Billion Yuan MT
Jun. 08 KPC Pharmaceuticals,Inc agreed to acquire 51% stake in China Resources Kunming Shenghuo Pharmaceutical Co., Ltd. from China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. for CNY 1.8 billion. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CR Sanjiu Medical and Pharmaceutical to Sell 51% of China Resources Shenghuo for 1.79 Billion Yuan
MT
KPC Pharmaceuticals,Inc agreed to acquire 51% stake in China Resources Kunming Shenghuo Pharmaceutical Co., Ltd. from China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. for CNY 1.8 billion.
CI
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 14 June 2024
CI
CR Sanjiu Ties Up With China Resources Power on New Energy Projects
MT
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
CR Sanjiu's 2023 Profit Climbs 16.5%, Revenue Jumps 37%
MT
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Proposes Cash Dividend
CI
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
China Resources Sanjiu Sees Up to 32% Jump in 2023 Profit
MT
CR Sanjiu Expects Increase in 2023 Profit
MT
Chongqing Changsheng Shenghe Pharmaceutical Private Equity Investment Fund Partnership Enterprise and China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. agreed to acquire 18.7751% stake in Runsheng Pharmaceutical Co., Ltd. from Chongqing Boyi Xintian Equity Investment Fund Partnership Enterprise (Limited Partnership), Tasly Capital and Chongqing Juxin Investment Co., Ltd. for CNY 58.9 million .
CI
Respirent Pharmaceutical Co.,Ltd. announced that it expects to receive CNY 127.97619 million in funding from China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., Chongqing Changsheng Shenghe Pharmaceutical Private Equity Investment Fund Partnership Enterprise
CI
China Resources Power Unit to Provide Financial Assistance to Affiliate
MT
CR Sanjiu Medical & Pharmaceutical Unit's Hypertension Drug Chosen for China's Centralized Procurement
MT
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
China Resources Sanjiu to Invest Up to 3.5 Billion Yuan in Bank Financial Products
MT
CR Sanjiu Medical & Pharmaceutical's H1 Attributable Profit Rises 31%
MT
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
CR Sanjiu Medical’s Analgesic Tablet Shortlisted For China’s Drug Procurement Program
MT
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Announces Implementation of Cash Dividend for 2022, Payable on 15 June 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 000999 Stock
  4. News China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.